Clinical studyTranscatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Prospective Assessment of the Right Inferior Phrenic Artery with C-arm CT
Section snippets
Patients
Our institutional review board approved this prospective study, and informed consent was obtained from all patients. From December 2007 to April 2008, C-arm CT of the RIPA was prospectively performed in 32 patients with HCCs that were suspected of having a blood supply from the RIPA. The patient population consisted of 27 men and five women (age range, 48–80 years; mean age, 64 years). A diagnosis of HCC was determined based on results of percutaneous needle biopsy (n = 4), surgical resection (n
Results
Tumor sizes ranged from 1.1 to 14 cm (mean size, 3.8 cm). Tumors were located in segment VII (n = 16), segment VIII (n = 12), segment IV (n = 3), and segment II (n = 1). Nine tumors were classified as single nodular, 20 as multinodular, and three as infiltrative. Tumor thrombi within the inferior vena cava were noted in four patients. All hepatic tumors abutted the liver surface or the diaphragm. Right inferior phrenic angiography was performed during the first to the 19th (mean, 6.1 sessions;
Discussion
The combination of vascular and soft tissue depiction of C-arm CT has potential benefits in the performance of chemoembolization, as the relationship of the targeted tumor with its arterial supply can be clearly identified (11, 12, 13, 14). Our results showed that C-arm CT of the RIPA provided additional information for 23 of 32 patients (72%) and resulted in a change in the procedure for three (9%). In this series, interestingly, a systemic-to-pulmonary shunt from the RIPA was observed in 22
References (25)
- et al.
Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival
Hepatology
(2003) - et al.
Novel advancements in the management of hepatocellular carcinoma in 2008
J Hepatol
(2008) - et al.
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics
J Hepatol
(2007) - et al.
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival
J Vasc Interv Radiol
(2005) - et al.
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma
J Vasc Interv Radiol
(2007) - et al.
Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies
J Vasc Interv Radiol
(2007) - et al.
Effect of C-arm CT on transcatheter arterial chemoembolization of liver tumors
J Vasc Interv Radiol
(2007) - et al.
Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization
J Vasc Interv Radiol
(2007) - et al.
Three-dimensional C-arm cone-beam CT: applications in the interventional suite
J Vasc Interv Radiol
(2008) - et al.
Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer
J Vasc Interv Radiol
(2002)
Transcatheter oily chemoembolization of the inferior phrenic artery in hepatocellular carcinoma: the safety and potential therapeutic role
J Vasc Interv Radiol
Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors
J Vasc Interv Radiol
Cited by (0)
None of the authors have identified a conflict of interest.